OCULAR BIOLOGY & IMAGING LAB at EAST TENNESSEE STATE UNIVERSITY

Search
Skip to content
  • The Kleinman Laboratory for Ocular Biology and Imaging
  • About Our Research
  • Team
    • Mark Kleinman
    • Researchers
    • Staff
    • Alumni
  • Publications
Publications

Molecular Imaging in the Human Eye

October 13, 2014 S. Lee Ware

We are working hard to develop new diagnostic imaging technologies to combat AMD.

Post navigation

Previous PostJennifer BrownNext PostSubhash C. Prajapati, PhD

Lab Contact

East Tennessee State University
James H. Quillen College of Medicine
Bldg 119 Rm 1-04
Johnson City, TN 37614
Department of Surgery
Ph (423) 439-5969
Fax (423) 439-6251
Email: kleinman@etsu.edu

Regarding Open Positions & Inquiries

We are always looking for highly self-motivated and creative individuals with an M.D. or doctoral-level training in the biological sciences. Our laboratory has several exciting and advanced avenues of investigation in non-invasive molecular-scale imaging modalities for aging retinal diseases and a program focused on dissecting the role of epigenetic regulation of inflammation and cell death in photoreceptors and retinal pigment epithelium.

Depending on project assignment, the candidate will gain critical skills in novel techniques in multi-modal small animal imaging, custom fluorophore bio-conjugate engineering, mass spectrometry based proteomics, massively parallel sequencing, bioinformatics pipelines, analyses to assess histone binding and modifications in genomic DNA, and numerous other advanced molecular biology techniques. Significant experience will be offered in the design and interpretation of experiments as well as grantsmanship to prepare the candidate for a successful independent career as a principal investigator in the biomedical sciences.

Candidates must be willing and comfortable working with rodents. Two year of eligibility and commitment as postdoctoral scholar is required. Preference will be given to those with experience in ocular biology specifically in the posterior segment, vascular biology, vision, neuroscience or aging research. Salary will be based on University guidelines for postdoctoral fellows, and will be commensurate with experience.

Interested applicants please submit CV, brief statement of interest and career goals, contact information and three references. In the CV, please list your technical expertise, especially in animal dissection and surgeries, optical coherence tomography, electrophysiology, histology/imaging/microscopy, mass spectrometry, massively parallel sequencing, bio-informatics, or other advanced techniques in molecular biology.

  • The Kleinman Laboratory for Ocular Biology and Imaging
  • About Our Research
  • Team
    • Mark Kleinman
    • Researchers
    • Staff
    • Alumni
  • Publications

Most Recent Lab News

  • Sushil Dubey, PhD
  • Subhash C. Prajapati, PhD
  • Molecular Imaging in the Human Eye
  • Jennifer Brown
  • Jacob Roney

Online Resources

  • Ambati Lab Lab of J. Ambati
  • Webvision – University of Utah Online Retina Texbook

RSS PubMed Record

  • Targeting of miR-33 ameliorates phenotypes linked to age-related macular degeneration March 21, 2021 Patricia A D'Amore
  • Imaging data on characterization of retinal autofluorescent lesions in a mouse model of juvenile neuronal ceroid lipofuscinosis (CLN3 disease) September 5, 2020 Mark E Kleinman
  • Loss of CLN3, the gene mutated in juvenile neuronal ceroid lipofuscinosis, leads to metabolic impairment and autophagy induction in retinal pigment epithelium June 28, 2020 Qing Jun Wang
  • Vision loss in juvenile neuronal ceroid lipofuscinosis (CLN3 disease) January 11, 2016 Qing Jun Wang

RSS Medscape Eye

  • Retained Lens Fragment After Cataract Surgery October 27, 2021
    All cataract surgeons will experience a retained lens fragment at some point. Depending on the size and makeup, these fragments can be managed medically and/or surgically. Medscape Ophthalmology
  • First Implant Approved for Wet Macular Degeneration October 26, 2021
    For the first time, an implant for age-related macular degeneration won approval from the FDA. Medscape Medical News
  • FDA Approves Drugs for Wet AMD, Macular Edema Due to Uveitis October 26, 2021
    Wet AMD gets Susvimo, an intravitreal ranibizumab injection, and macular edema gets Xipere, a triamcinolone acetonide injectable suspension. FDA Approvals
  • A Review of Central Retinal Artery Occlusion October 25, 2021
    Philippe Gabriel Steg, MD, discusses a recent review of central retinal artery occlusion for cardiologists who may not be familiar with the condition. theheart.org on Medscape
Blog at WordPress.com.